Patents by Inventor Javier Forn Dalmau

Javier Forn Dalmau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6610745
    Abstract: Neurodegenerative diseases, such as dementia, including Alzheimer's disease, can be treated or prevented by administering an effective amount of triflusal or its metabolite, or a pharmaceutically acceptable salt or a prodrug thereof.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: August 26, 2003
    Assignee: J. Uriach & Cia, S.A.
    Inventors: Manuel Merlos Roca, Alberto Fernandez De Arriba, Fernando Cavalcanti De Maria, Agustí Miralles Acosta, Mariano Sanchez Crespo, Julián Garcia Rafanell, Javier Forn Dalmau
  • Publication number: 20030032630
    Abstract: Neurodegenerative diseases, such as dementia, including Alzheimer's disease, can be treated or prevented by administering an effective amount of triflusal or its metabolite, or a pharmaceutically acceptable salt or a prodrug thereof.
    Type: Application
    Filed: April 4, 2002
    Publication date: February 13, 2003
    Inventors: Manuel Merlos Roca, Alberto Fernandez De Arriba, Fernando Cavalcanti De Maria, Agusti Miralles Acosta, Mariano Sanchez Crespo, Julian Garcia Rafanell, Javier Forn Dalmau
  • Patent number: 6509377
    Abstract: A method for inhibiting the activation of transcription factor NF-&kgr;B in a warm-blooded animal in need thereof, comprises administering to said animal an effective amount of a compound of formula I wherein R represents hydrogen or COCH3, or a pharmaceutically acceptable salt or a prodrug thereof.
    Type: Grant
    Filed: April 9, 2002
    Date of Patent: January 21, 2003
    Assignee: J. Uriach & Cia, S.A.
    Inventors: Manuel Merlos Roca, Alberto Fernandez De Arriba, Fernando Cavalcanti De Maria, Agustí Miralles Acosta, Mariano Sanchez Crespo, Julián Garcia Rafanell, Javier Forn Dalmau
  • Patent number: 6414025
    Abstract: The invention relates to the use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-&kgr;B. The invention also relates to the utilization of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives for the preparation of medicaments to treat or prevent of pathologies associated to the activation of NF-&kgr;B and/or the expression of genes which are dependent on or regulated by, at least partially, NF&kgr;B in mammals, including humans.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: July 2, 2002
    Assignee: J. Uriach & Cia, S.A.
    Inventors: Manuel Merlos Roca, Alberto Fernandez De Arriba, Fernando Cavalcanti De Maria, Agustí Miralles Acosta, Mariano Sanchez Crespo, Julián Garcia Rafanell, Javier Forn Dalmau